Nymox Pharmaceutical Corp (NYMXF)
0.257
+0.01
(+2.59%)
USD |
OTCM |
May 10, 16:00
Nymox Pharmaceutical Max Drawdown (5Y): 95.87% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 95.87% |
| March 31, 2024 | 95.87% |
| February 29, 2024 | 95.87% |
| January 31, 2024 | 95.87% |
| December 31, 2023 | 95.87% |
| November 30, 2023 | 95.87% |
| October 31, 2023 | 95.87% |
| September 30, 2023 | 95.87% |
| August 31, 2023 | 95.87% |
| July 31, 2023 | 95.87% |
| June 30, 2023 | 95.87% |
| May 31, 2023 | 95.30% |
| April 30, 2023 | 95.30% |
| March 31, 2023 | 95.30% |
| February 28, 2023 | 95.30% |
| January 31, 2023 | 95.30% |
| December 31, 2022 | 95.30% |
| November 30, 2022 | 95.30% |
| October 31, 2022 | 95.30% |
| September 30, 2022 | 95.30% |
| August 31, 2022 | 95.30% |
| July 31, 2022 | 95.30% |
| June 30, 2022 | 91.84% |
| May 31, 2022 | 91.74% |
| April 30, 2022 | 80.87% |
| Date | Value |
|---|---|
| March 31, 2022 | 80.87% |
| February 28, 2022 | 80.87% |
| January 31, 2022 | 80.87% |
| December 31, 2021 | 80.87% |
| November 30, 2021 | 77.34% |
| October 31, 2021 | 77.34% |
| September 30, 2021 | 77.34% |
| August 31, 2021 | 77.34% |
| July 31, 2021 | 77.34% |
| June 30, 2021 | 77.34% |
| May 31, 2021 | 80.19% |
| April 30, 2021 | 80.19% |
| March 31, 2021 | 80.19% |
| February 28, 2021 | 80.19% |
| January 31, 2021 | 80.19% |
| December 31, 2020 | 80.19% |
| November 30, 2020 | 80.19% |
| October 31, 2020 | 80.19% |
| September 30, 2020 | 80.19% |
| August 31, 2020 | 80.19% |
| July 31, 2020 | 80.19% |
| June 30, 2020 | 80.19% |
| May 31, 2020 | 80.19% |
| April 30, 2020 | 87.69% |
| March 31, 2020 | 87.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.34%
Minimum
Jun 2021
96.45%
Maximum
May 2019
88.66%
Average
93.46%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.12 |
| Beta (5Y) | 0.3496 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 136.9% |
| Historical Sharpe Ratio (5Y) | -0.2207 |
| Historical Sortino (5Y) | -0.5703 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.38% |